Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Naphthamidine urokinase inhibitors

Naphthamidine urokinase inhibitors

US Patent 6495562 · Granted Dec 17, 2002

Estimated economic value: $55,981,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Apoptosis inducing agents for the treatment of cancer and immune and autoimmune 2024
Synthesis of novel ketone body analogs for use as a nutritional supplement2023
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune 2023
Anti-c-Met antibody drug conjugates2023
Anti-viral compounds2018
Anti-viral compounds2018
Apoptosis-induced agents for the treatment of cancer and immune and autoimmune d2018
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune 2017
Pyrrolo [2,3-B] pyridine CDK9 kinase inhibitors2017
Pyrrolo [2,3-B] pyridine CDK9 kinase inhibitors2017
Pyridine CDK9 kinase inhibitors2017
Antiviral compounds and uses thereof2017